Jack Fuller

Jack Fuller

Greater Boston
2K followers 500+ connections

Join to view profile

About

I am a catalyst for transformation and growth within my organization. Always striving to…

Articles by Jack

Activity

Join now to see all activity

Experience

  • HealthVerity Graphic

    HealthVerity

    Greater Boston Area

  • -

  • -

    Greater Boston Area

  • -

    Greater Boston Area

  • -

Education

Licenses & Certifications

Publications

  • Assessing Your Fundraising Acumen

    The perfect fit, the good fit, and the stretcher. Those are the three types of scientist-entrepreneurs I’ve seen do well in their fundraising efforts.

    Day in and day out, LSN works with life science companies that are raising capital, and we see an enormous number of talented and intelligent people who cannot conceptualize and execute an outbound fundraising campaign. For one reason or another, otherwise smart people are not able to determine who to approach for capital or discuss their…

    The perfect fit, the good fit, and the stretcher. Those are the three types of scientist-entrepreneurs I’ve seen do well in their fundraising efforts.

    Day in and day out, LSN works with life science companies that are raising capital, and we see an enormous number of talented and intelligent people who cannot conceptualize and execute an outbound fundraising campaign. For one reason or another, otherwise smart people are not able to determine who to approach for capital or discuss their ideas and technology in a clear and convincing manner....

    See publication

  • The Life Science Executive's Fundraising Manifesto: Best Practices for Identifying Capital in the Biotech and Medtech Arenas

    A primary objective for life science executives is raising capital. Very often, however, a lack of marketing and sales skills impedes their efforts. Focusing regionally, rather than globally, only compounds the challenge. "The Life Science Executive's Fundraising Manifesto" helps scientists understand the fundamental skills needed to brand and market their companies. It discusses how to use a consistent message to achieve compelling results from a fundraising campaign, and it teaches you how to…

    A primary objective for life science executives is raising capital. Very often, however, a lack of marketing and sales skills impedes their efforts. Focusing regionally, rather than globally, only compounds the challenge. "The Life Science Executive's Fundraising Manifesto" helps scientists understand the fundamental skills needed to brand and market their companies. It discusses how to use a consistent message to achieve compelling results from a fundraising campaign, and it teaches you how to aggregate a list of potential global investors that are a fit for your company's products and services. The book also explains how to efficiently and effectively reach out to potential investor targets, start a dialogue that fosters a relationship, and ultimately secure capital allocations. Raising capital is not a one-time event. It must be an ongoing part of your business strategy. This book reveals the expertise required to continually fundraise and bring your ideas to market. For more information about the book, please visit www.fundraisingmanifesto.com.

    Other authors
    See publication

  • What Should the Next Generation of Incubators Look Like?

    If you reside in one of the many growing or established life science clusters around the U.S., you have probably encountered the growing plethora of incubators or accelerators that are emerging to support nascent and semi-virtual companies. Often, these incubators are funded by a combination of state grants, corporate partnerships, and revenue generated from renting space to emerging companies.

    When giving a tour, incubators are quick to point out the pristine lab space and glass-walled…

    If you reside in one of the many growing or established life science clusters around the U.S., you have probably encountered the growing plethora of incubators or accelerators that are emerging to support nascent and semi-virtual companies. Often, these incubators are funded by a combination of state grants, corporate partnerships, and revenue generated from renting space to emerging companies.

    When giving a tour, incubators are quick to point out the pristine lab space and glass-walled conference rooms they provide to start-ups. However, they often have little knowledge about what it takes to fundraise in the life sciences: a tactical approach that requires expertise in branding, marketing, and cloud infrastructure.

    See publication

  • Fundraising Tactics: Communicating Clearly with Taglines

    Life Science companies pitching investors have a tough job: It’s not easy to convince people to invest in a capital-intensive industry with a low rate of product commercialization. Then there’s the challenge of conveying an extremely specialized and complex idea to people who want to net out the technology quickly. To be successful, companies must work hard to communicate complex ideas at a level that is easily understood by all potential investors, not just the “science-literate.” As Charles…

    Life Science companies pitching investors have a tough job: It’s not easy to convince people to invest in a capital-intensive industry with a low rate of product commercialization. Then there’s the challenge of conveying an extremely specialized and complex idea to people who want to net out the technology quickly. To be successful, companies must work hard to communicate complex ideas at a level that is easily understood by all potential investors, not just the “science-literate.” As Charles Bukowski once said “Genius could be the ability to say a profound thing in a simple way.”

    The first place this needs to be accomplished is in a company’s tagline. Taglines are ubiquitous in the industry, but very rarely does a tagline accurately summarize that “special sauce” that makes a company so exceptional. Prospects should be able to read a tagline and grasp the goal of the company.

    See publication

  • How to Organize Your Outbound Fundraising Infrastructure

    LSN regularly hosts a fundraising bootcamp at the for life science entrepreneurs at incubators, universities conferences, and other venues globally. The purpose of this bootcamp series is to provide a tactical overview on how to manage an effective outbound fundraising campaign for early stage life sciences companies.

    The main points of focus in the workshop are:

    · positioning, branding and marketing collateral

    · Creating a global target list

    ·…

    LSN regularly hosts a fundraising bootcamp at the for life science entrepreneurs at incubators, universities conferences, and other venues globally. The purpose of this bootcamp series is to provide a tactical overview on how to manage an effective outbound fundraising campaign for early stage life sciences companies.

    The main points of focus in the workshop are:

    · positioning, branding and marketing collateral

    · Creating a global target list

    · Launching a campaign

    · Creating a dialogue with potential investors

    See publication

  • Interpreting Unsuccessful Investor Conversations

    Let’s face it, much of the time a fundraising executive spends courting potential investors leads to rejections. If the opposite were true, our writers and researchers here at LSN would have much less to talk about, and CEOs of biotech and medtechs would be able to spend a good deal more time on bringing a product to market. However, most savvy entrepreneurs understand that fundraising is a numbers game, and eventually their perseverance will pay off in the form of an allocation. However, few…

    Let’s face it, much of the time a fundraising executive spends courting potential investors leads to rejections. If the opposite were true, our writers and researchers here at LSN would have much less to talk about, and CEOs of biotech and medtechs would be able to spend a good deal more time on bringing a product to market. However, most savvy entrepreneurs understand that fundraising is a numbers game, and eventually their perseverance will pay off in the form of an allocation. However, few entrepreneurs spend enough time thinking about the investors that have said “no.” However, they are often not all saying the same thing, so paying attention to these rejections can be a helpful guide in improving your fundraising efforts going forward.

    See publication

  • A Word on When to go Outbound

    Many of the people we talk to here at LSN are convinced that a pre-existing relationship or a referral from a close associate are the only ways to engage potential investors. LSN has gone to great lengths to dispel this deeply engrained myth in the life sciences. However, helping an entrepreneur to grasp the significant advantage of approaching investors based on fit is not nearly as difficult as convincing them to actually do it. All too often, fundraising executives agree that the principle…

    Many of the people we talk to here at LSN are convinced that a pre-existing relationship or a referral from a close associate are the only ways to engage potential investors. LSN has gone to great lengths to dispel this deeply engrained myth in the life sciences. However, helping an entrepreneur to grasp the significant advantage of approaching investors based on fit is not nearly as difficult as convincing them to actually do it. All too often, fundraising executives agree that the principle of “fit vs. referral” makes absolute sense, yet they exclusively reach out to people within their network to source a new round of capital.

    See publication

  • Emerging Life Science Clusters

    As a Boston-based company, Life Science Nation is by all accounts located in one of the greatest life science hubs in the world. An emerging company that can claim residence in Kendall Square somehow finds a certain level of implied acumen simply by virtue of being there. Investors also tend to gravitate toward the east and west coast “superclusters” when setting up offices. So how do companies outside of these geographic areas find and engage potential investors, given this apparent…

    As a Boston-based company, Life Science Nation is by all accounts located in one of the greatest life science hubs in the world. An emerging company that can claim residence in Kendall Square somehow finds a certain level of implied acumen simply by virtue of being there. Investors also tend to gravitate toward the east and west coast “superclusters” when setting up offices. So how do companies outside of these geographic areas find and engage potential investors, given this apparent disadvantage?

    See publication

  • In Oncology Investing, Knowledge is a Big Advantage

    Therapies targeting cancer indications have historically gotten a lot of attention in the healthcare industry. As the new categories of direct investors in biotechnology continue to grow savvier in the sector, funding cancer therapeutics remains the most attractive economic and philanthropic opportunity.

    See publication

  • Gorillas at the Table: Corporate Venture Capital

    The growing role of Corporate Venture Capital (CVC) in driving early stage enterprises in the life science sector has been well documented and dissected. The majority of corporate investments are structured in four forms: direct investments from the parent company, wholly owned subsidiaries, independent organizations with dedicated funds, and as limited partners in other funds. Understanding the type of corporate investment makes an enormous difference in the type of investment they are looking…

    The growing role of Corporate Venture Capital (CVC) in driving early stage enterprises in the life science sector has been well documented and dissected. The majority of corporate investments are structured in four forms: direct investments from the parent company, wholly owned subsidiaries, independent organizations with dedicated funds, and as limited partners in other funds. Understanding the type of corporate investment makes an enormous difference in the type of investment they are looking to make.

    See publication

  • Temperature-Sensitive Transitions Below LCST in Amphiphilic Dendritic Assemblies – Host-Guest Implications

    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

    Oligoethylene glycol decorated supramolecular assemblies have been of great interest due to their charge-neutral character and thus the propensity to avoid non-specific interactions. These systems are known to exhibit a macroscopic temperature-sensitive transition, where the assembly phase separates from the aqueous phase at higher temperatures. While this so-called lower critical solution temperature (LCST) behavior has been well-studied, there have been no studies on the fate of these…

    Oligoethylene glycol decorated supramolecular assemblies have been of great interest due to their charge-neutral character and thus the propensity to avoid non-specific interactions. These systems are known to exhibit a macroscopic temperature-sensitive transition, where the assembly phase separates from the aqueous phase at higher temperatures. While this so-called lower critical solution temperature (LCST) behavior has been well-studied, there have been no studies on the fate of these supramolecular assemblies below this transition temperature. The work here brings to light the presence of a second, sub-LCST transition, observed well below the LCST of oligoethylene glycol (OEG) based dendrons, where the host-guest properties of the assembly are significantly altered. This sub-LCST transition is accompanied by changes in the guest encapsulation stability and dynamics of host exchange.

    Other authors

More activity by Jack

View Jack’s full profile

  • See who you know in common
  • Get introduced
  • Contact Jack directly
Join to view full profile

Other similar profiles

Explore more posts

Explore collaborative articles

We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.

Explore More

Others named Jack Fuller in United States

130 others named Jack Fuller in United States are on LinkedIn

See others named Jack Fuller

Add new skills with these courses

See all courses